Found 5 results

Author [ Title] Type Year

Filters: Author is Buggage, R  [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 

4

R. N. Nussenblatt, Buggage, R., Thompson, D., Zhuqing, L., Ragheb, J., and Waldmann, T., “4 Year Daclizumab Therapy for Sight Threatening Uveitis”, in Annual Meeting of the Federation of Clinical Immunology Societies, San Francisco, CA, 2002.

D

R. Nussenblatt, Li, Z., Robinson, R., Shames, R., Tang, M., Mailman, M., Thompson, D., Peterson, J., Sen, H., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Sran, P., Waldmann, T., and Buggage, R., “Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy”, 2003.

I

H. N. Sen, Buggage, R., Hammel, K., Levy-Clarke, G., and Nussenblatt, R., “Infliximab for the Treatment of Scleritis and Recalcitrant Uveitis”, 2008.

M

R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R., “A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease”, 2003.

S

R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R., “A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease”, 2003.